Contact this trialFirst, we need to learn more about you.
Selective Estrogen Receptor Modulator
Endoxifen for Bipolar Disorder
Recruiting1 awardPhase 3
Peachtree Corners,, Georgia
This trial aims to test the effectiveness and safety of an 8 mg dose of Endoxifen in Bipolar I disorder patients compared to a placebo. The goal is to show that Endoxifen works
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.